                               SEQUENCE LISTING

<110> JANSSEN PHARMACEUTICA, NV
 
<120> METHODS OF TREATING SEVERE NON-DIABETIC OBESITY

<130> 106132.000304

<140> PCT/IB2019/051915
<141> 2019-03-08

<150> 62/640,463
<151> 2018-03-08

<160> 2     

<170> PatentIn version 3.5

<210> 1
<211> 37
<212> PRT
<213> Homo sapiens

<400> 1
His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


<210> 2
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> MOD_RES
<222> (2)..(2)
<223> 2-aminoisobutyric acid 

<400> 2
His Xaa Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Lys Arg Ala Lys Glu Phe Val Gln Trp Leu Met Asn Thr Cys 
            20                  25                  30  


